41/137US=16 / Câncer
Marriott SJ. Oncogenic potential of the HTLV-1 tax protein. In: Khalili K, Jeang KT. Viral oncology: basic science and clinical applications. New Jersey: Wiley-Blackwell, 2010. p. 295-315. ISBN 978-0-470-37991-2.

HTLV-1; VIRUS LINTROFOTROPICO DE CELULAS T HUMANO TIPO 1; TAX


42/137US=6 / Quimioterapia
Airley R. Checkpoint protein kinases as novel targets - mammalian target of rapamycin (mTOR). In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 245-8. ISBN 978-0-470-09254-5.

CHECKPOINT; PROTEINAS QUINASES; MTOR; ALVO DA RAPAMICINA EM MAMIFEROS; ATIVACAO DE MTOR; ANTICANCERIGENOS ALVO MTOR


43/137US=8 / Laboratório
Kaufman RJ, Popolo L. Protein synthesis, processing, and trafficking. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 25-33. ISBN 978-0-443-06715-0.

SINTESE DE PROTEINAS; REGULACAO DA TRADUCAO DO MRNA; CLASSIFICACAO DAS PROTEINAS; ENOVELAMENTO DE PROTEINAS; DEGRADACAO DA PROTEINA; TRIAGEM DO CITOSSOL; PROTEINAS NUCLEARES; PROTEINAS MITOCONDRIAIS; PROTEINAS PEROXISSOMAIS; VIAS SECRETORAS


44/137US=8 / Laboratório
Lecker SH, Saric T, Goldberg AL. Protein degradation in cells. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 34-41. ISBN 978-0-443-06715-0.

DEGRADACAO DE PROTEINAS; PROTEOLISE LISOSSOMAL; CONJUGACAO DA UBIQUITINA; INIBIDORES DE PROTEASSOMA; TERAPIA DO CANCER; DEGRADACAO ASSOCIADA AO RETICULO ENDOPLASMATICO; PROTEOLISE EM MITOCONDRIA; QUEBRA DE PROTEINA MUSCULAR; CAQUEXIA


45/137US=8 / Laboratório
Rigby AC, Furie B, Furie BC. Protein architecture: relationship of form and function. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 42-8. ISBN 978-0-443-06715-0.

AMINOACIDOS; LIGACAO PEPTIDICA; ELEMENTOS DE ESTRUTURA SECUNDARIA DE PROTEINAS; HELICE ALFA; FOLHA DE &*946;; &*946;-PREGUEADA FOLHA; DOMINIOS PROTEICOS


46/137US=48 / Biol/Mol
Chatterjee M, Wojciechowski J, Tainsky MA. Discovery and antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput. In: Tainsky MA. Tumor biomarker discovery: methods and protocols. New Jersey: Humana Press, 2009. p. 21-38. (Methods in Molecular Biology 520) ISBN 978-1-60327-810-2.

RESPOSTA IMUNE; BIOMARCADORES TUMORAIS; AUTO-ANTICORPOS; EPITOPOS; DETERMINANTE ANTIGENICO; MICROARRAYS DA PROTEINA; IMUNOTERAPIA


47/137US=48 / Biol/Mol
Patwa TH, Qiu Y, Zhao J, Simeone DM, Lubman DM. All-liquid separations, protein microarrays, and mass spectrometry to interrogate serum proteomes: an application to serum glycoproteomics. In: Tainsky MA. Tumor biomarker discovery: methods and protocols. New Jersey: Humana Press, 2009. p. 75-87. (Methods in Molecular Biology 520) ISBN 978-1-60327-810-2.

IMMUNODEPLETION; LECITINA ENRIQUECIDA; NPS-RP-HPLC; GLIGOPROTEINA MICROARRAY; MAPEAMENTO DESGLICOSILACAO


48/137US=48 / Biol/Mol
Espina V, Liotta LA, Petricoin III EF. Reverse-phase protein microarrays for theranostics and patient tailored therapy. In: Tainsky MA. Tumor biomarker discovery: methods and protocols. New Jersey: Humana Press, 2009. p. 89-105. (Methods in Molecular Biology 520) ISBN 978-1-60327-810-2.

CANCER; MICRODISSECCAO; CAPTURA A LASER; MICROARRAY; PERFIL MOLECULAR; PROTEINA; PROTEOMICA; HETEROGENEIDADE DO TECIDO; TERAPEUTICA; DIAGNOSTICO


49/137US=48 / Biol/Mol
Moeder CB, Giltane JM, Moulis SP, Rimm DL. Quantitative, fluorescence-based in situ assessment of protein expression. In: Tainsky MA. Tumor biomarker discovery: methods and protocols. New Jersey: Humana Press, 2009. p. 163-75. (Methods in Molecular Biology 520) ISBN 978-1-60327-810-2.

IMUNO-HISTOQUIMICA; ANALISE QUANTITATIVA; BIOMARCADORES; AQUA; TECIDO MICROARRAYS


50/137US=78 / Biol/Mol
Guy B. Adjuvants for protein-and carbohydrate-based vaccines. In: Guo Z, Boons G-J, editors. Carbohydrate-based vaccines and immunotherapies. New Jersey: Willey, 2009. p. 89-115. (Drug Discovery and Development) ISBN 978-0-470-19756-1.

PROTEINAS; CARBOIDRATOS; VACINAS ADJUVANTES; RESPOSTA ADAPTATIVA; IMUNIDADE INATA


51/137US=85 / Biol/Mol
Lee SE, Lim JW, Kim H. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 163-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

DHA; AP-1; APOPTOSE; CELULAS DE CANCER GASTRICO


52/137US=85 / Biol/Mol
Song NY, Kim DH, Kim EH, Na HK, Surh YJ. 15-Deoxy-&*916; 12,14-prostaglandin J² induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 210-6. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

15-DESOXI-&*916; J² 12,14-PROSTAGLANDINA; P53; MULTIRRESISTENCIA PROTEINA ASSOCIADA 1; CELULAS HUMANAS DE CANCER DE MAMA


53/137US=85 / Biol/Mol
Kim MS, Kwon JY, Kang NJ, Lee KW, Lee HJ. Phloretin induces apoptosis in H-Ras MCF10A human breast tumor cells through the activation of p53 via JNK and p38 mitogen-activated protein kinase signaling. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 479-83. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

APOPTOSE; CANCER DE MAMA; JNK; P38 MAPK; FLORETINA


54/137US=85 / Biol/Mol
Lee YK, Hwang JT, Lee MS, Kim YM, Park OJ. Kidney bean husk extracts exrc antitumor effect by inducing apoptosis involving AMP-activated protein kinase signaling pathway. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 484-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CASCA DE FEIJAO; APOPTOSE; AICAR; EFEITOS ANTITUMORAIS; HT-29 DO COLON CELULAS CANCEROSAS; P53 TIPO SELVAGEM


55/137US=85 / Biol/Mol
Kim SH, Kim SH, Kim YB, Jeon YT, Lee SC, Song YS. Genistein inhibits cell growth by modulating various mitogen-activated protein kinases and AKT in cervical cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 495-500. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

GENISTEINA; ERK1/2; P38; MARK; JNK; AKT


56/137US=85 / Biol/Mol
Hsuuw YD, Kuo TF, Lee KH, Liu YT, Huang YT, Lai CY, Chan WH. Ginkgolide B induces apoptosis via activation of JNK and p21-Activated protein kinase 2 in mouse embryonic stem cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 501-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

GINKGOLIDE B; APOPTOSE; JNK; PAK2


57/137US=85 / Biol/Mol
Lim JW, Song JY, Seo JY, Kim H, Kim KH. Role of pancreatitis-associated protein 1 on oxidative stress-induced cell death of pancreatic acinar cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 545-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

PANCREATITE PROTEINA ASSOCIADA 1; MORTE CELULAR; ACINARES CELULAS PANCREATICAS


58/137US=85 / Biol/Mol
Hanif IM, Ahmad KA, Ahmed K, Pervaiz S. Involvement of reactive oxygen species in apoptosis induced by pharmacological inhibition of protein kinase CK2. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 591-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CELULAS DE LEUCEMIA HUMANAS; CK2; APOPTOSE; ROS


59/137US=96 / Biol/Mol
Giuseppe GT, Carruba G, Cocciadiferro L, Granata OM, Nicotra CMA. Low levels of both xanthine dehydrogenase and cellular retinol binding protein are responsible for retinoic acid degiciency in malignant human mannary epithelial cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 268-72. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ALL-TRANS-RETINOICO; TUMORAIS CELULAS EPITELIAIS MAMARIAS; XANTINA-DESIDROGENASE; CELULAR PROTEINA RETINOL; PROTEINA ACIDO RETINOICO CELULAR VINCULATIVO; BIOSSINTESE DE ACIDO RETINOICO


60/137US=23-D / Câncer
Zaika AI, Hong SM. Extrahepatic bile duct carcinoma: role of the p53 protein family. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 441-9. ISBN 978-1-4020-9803-1.

EXTRA-HEPATICO CARCINOMA DO DUCTO BILIAR; PROTEINA P53


Primeira | Anterior | Próxima | Última